NewEdge Advisors’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

NewEdge Advisors’s Portfolio NMRD Stock Details NMRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-360	Closed	-$79	–	4008
2023 Q4	$79	Hold	360	–	–	﹤0.01%	3651
2023 Q3	$113	Hold	360	–	–	﹤0.01%	3365
2023 Q2	$333	Hold	360	–	–	﹤0.01%	3351
2023 Q1	$322	Hold	360	–	–	﹤0.01%	3282
2022 Q4	$1	Buy	+360	New	+$794	﹤0.01%	4064

Other funds holding NMRD

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

NewEdge Advisors's NMRD Position: Q1 2024 in Review

NewEdge Advisors sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 360 shares — an estimated $79 sold.

NewEdge Advisors first reported a position in NMRD in Q4 2022 and held it in 5 quarters. The position peaked at $333 in Q2 2023. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

NewEdge Advisors reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
NewEdge Advisors sold 360 Nemaura Medical, Inc. Common Stock shares in Q1 2024, an estimated $79.
NewEdge Advisors first reported a position in Nemaura Medical, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
NewEdge Advisors's Nemaura Medical, Inc. Common Stock position peaked at $333 in Q2 2023.
2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on NewEdge Advisors's 13F filing for Q1 2024, filed 14 May 2024.